The global advanced balloon catheter market size accounted for USD 3.01 billion in 2024, grew to USD 3.30 billion in 2025 and is predicted to surpass around USD 7.46 billion by 2034, representing a healthy CAGR of 9.50% between 2024 and 2034.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Advanced Balloon Catheter Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Advanced Balloon Catheter Market, by Raw Material Type, 2024-2034
8.1.1 Nylon
8.1.1.1. Market Revenue and Forecast (2021-2034)
8.1.2. PET (polyethylene terephthalate)
8.1.2.1. Market Revenue and Forecast (2021-2034)
8.1.3. Polyurethane
8.1.3.1. Market Revenue and Forecast (2021-2034)
8.1.4. Others
8.1.4.1. Market Revenue and Forecast (2021-2034)
9.1. Advanced Balloon Catheter Market, by Application Type, 2024-2034
9.1.1. Coronary Procedures
9.1.1.1. Market Revenue and Forecast (2021-2034)
9.1.2. Peripheral Procedures
9.1.2.1. Market Revenue and Forecast (2021-2034)
9.1.3. Neurovascular Procedures
9.1.3.1. Market Revenue and Forecast (2021-2034)
9.1.4. Other Procedures
9.1.4.1. Market Revenue and Forecast (2021-2034)
10.1. Advanced Balloon Catheter Market, by End User Type, 2024-2034
10.1.1. Hospitals and Ambulatory Surgical Centers
10.1.1.1. Market Revenue and Forecast (2021-2034)
10.1.2. Catheterization Laboratories
10.1.2.1. Market Revenue and Forecast (2021-2034)
10.1.3. Others
10.1.3.1. Market Revenue and Forecast (2021-2034)
11.1. North America
11.1.1. Market Revenue and Forecast, by Raw Material Type (2021-2034)
11.1.2. Market Revenue and Forecast, by Application Type (2021-2034)
11.1.3. Market Revenue and Forecast, by End User Type (2021-2034)
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Raw Material Type (2021-2034)
11.1.4.2. Market Revenue and Forecast, by Application Type (2021-2034)
11.1.4.3. Market Revenue and Forecast, by End User Type (2021-2034)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Raw Material Type (2021-2034)
11.1.5.2. Market Revenue and Forecast, by Application Type (2021-2034)
11.1.5.3. Market Revenue and Forecast, by End User Type (2021-2034)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Raw Material Type (2021-2034)
11.2.2. Market Revenue and Forecast, by Application Type (2021-2034)
11.2.3. Market Revenue and Forecast, by End User Type (2021-2034)
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Raw Material Type (2021-2034)
11.2.4.2. Market Revenue and Forecast, by Application Type (2021-2034)
11.2.4.3. Market Revenue and Forecast, by End User Type (2021-2034)
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Raw Material Type (2021-2034)
11.2.5.2. Market Revenue and Forecast, by Application Type (2021-2034)
11.2.5.3. Market Revenue and Forecast, by End User Type (2021-2034)
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Raw Material Type (2021-2034)
11.2.6.2. Market Revenue and Forecast, by Application Type (2021-2034)
11.2.6.3. Market Revenue and Forecast, by End User Type (2021-2034)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Raw Material Type (2021-2034)
11.2.7.2. Market Revenue and Forecast, by Application Type (2021-2034)
11.2.7.3. Market Revenue and Forecast, by End User Type (2021-2034)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Raw Material Type (2021-2034)
11.3.2. Market Revenue and Forecast, by Application Type (2021-2034)
11.3.3. Market Revenue and Forecast, by End User Type (2021-2034)
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Raw Material Type (2021-2034)
11.3.4.2. Market Revenue and Forecast, by Application Type (2021-2034)
11.3.4.3. Market Revenue and Forecast, by End User Type (2021-2034)
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Raw Material Type (2021-2034)
11.3.5.2. Market Revenue and Forecast, by Application Type (2021-2034)
11.3.5.3. Market Revenue and Forecast, by End User Type (2021-2034)
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Raw Material Type (2021-2034)
11.3.6.2. Market Revenue and Forecast, by Application Type (2021-2034)
11.3.6.3. Market Revenue and Forecast, by End User Type (2021-2034)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Raw Material Type (2021-2034)
11.3.7.2. Market Revenue and Forecast, by Application Type (2021-2034)
11.3.7.3. Market Revenue and Forecast, by End User Type (2021-2034)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Raw Material Type (2021-2034)
11.4.2. Market Revenue and Forecast, by Application Type (2021-2034)
11.4.3. Market Revenue and Forecast, by End User Type (2021-2034)
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Raw Material Type (2021-2034)
11.4.4.2. Market Revenue and Forecast, by Application Type (2021-2034)
11.4.4.3. Market Revenue and Forecast, by End User Type (2021-2034)
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Raw Material Type (2021-2034)
11.4.5.2. Market Revenue and Forecast, by Application Type (2021-2034)
11.4.5.3. Market Revenue and Forecast, by End User Type (2021-2034)
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Raw Material Type (2021-2034)
11.4.6.2. Market Revenue and Forecast, by Application Type (2021-2034)
11.4.6.3. Market Revenue and Forecast, by End User Type (2021-2034)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Raw Material Type (2021-2034)
11.4.7.2. Market Revenue and Forecast, by Application Type (2021-2034)
11.4.7.3. Market Revenue and Forecast, by End User Type (2021-2034)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Raw Material Type (2021-2034)
11.5.2. Market Revenue and Forecast, by Application Type (2021-2034)
11.5.3. Market Revenue and Forecast, by End User Type (2021-2034)
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Raw Material Type (2021-2034)
11.5.4.2. Market Revenue and Forecast, by Application Type (2021-2034)
11.5.4.3. Market Revenue and Forecast, by End User Type (2021-2034)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Raw Material Type (2021-2034)
11.5.5.2. Market Revenue and Forecast, by Application Type (2021-2034)
11.5.5.3. Market Revenue and Forecast, by End User Type (2021-2034)
12.1. Abbott Laboratories
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Boston Scientific Corporation
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Medtronic plc
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. erumo Corporation
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. MicroPort
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Scientific Corporation
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. B. Braun Melsungen AG
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Meril Life Sciences Pvt. Ltd.
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Hexacath
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Tokai Medical Products Inc.
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
14.1. About Us
14.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample